Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 134

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 134
---
 diluted earnings per share

                                                                                                  For the Years Ended December 31                                                                           
                                                                                                  2024                                                   2023                       2022                    
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Numerator                                                                                                                                                                                                 
  Net loss from continuing operations                                                             $                                    ( 17,637,783      $         ( 8,434,781      $         ( 25,007,905  
  Less: Net (loss) income attributable to noncontrolling interest from continuing operations                                               ( 34,287                      3,377                    ( 65,124  
  Net loss attributable to common shareholders, basic                                             $                                    ( 17,603,496      $         ( 8,438,158      $         ( 24,942,781  
  Denominator                                                                                                                                                                                               
  Weighted average number of shares outstanding, basic and diluted                                                                       32,459,921                 22,900,631                  12,029,656  
  Loss per share, basic and diluted                                                               $                                          ( 0.54      $              ( 0.37      $               ( 2.07  

The
Company calculates basic and diluted earnings/ (loss) per share for discontinued operations as follows:

                                                                        For the Years Ended December 31                                                                       
                                                                        2024                                                 2023                       2022                  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Numerator                                                                                                                                                                   
  Net income/(loss) attributable to common shareholders, basic          $                                     2,246,340      $         ( 1,601,323      $             58,659  
  Denominator                                                                                                                                                                 
  Weighted average number of shares outstanding, basic and diluted                                           32,459,921                 22,900,631                12,029,656  
  Earnings/ (loss) per share, basic and diluted                         $                                          0.07      $              ( 0.07      $               0.00  

As
of December 31, 2024, the Company had dilutive securities from the outstanding convertible notes and warrants convertible into 36,517 4,458,625

As
of December 31, 2023, the Company had dilutive securities from the outstanding convertible notes and warrants convertible into 422,625 4,458